WallStreetZenWallStreetZen

NASDAQ: UNCY
Unicycive Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for UNCY

Based on 3 analysts offering 12 month price targets for Unicycive Therapeutics Inc.
Min Forecast
$3.00+105.48%
Avg Forecast
$4.50+208.22%
Max Forecast
$6.00+310.96%

Should I buy or sell UNCY stock?

Based on 3 analysts offering ratings for Unicycive Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UNCY stock forecasts and price targets.

UNCY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-14
lockedlocked$00.00+00.00%2024-02-14
lockedlocked$00.00+00.00%2023-12-04

1 of 1

Forecast return on equity

Is UNCY forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is UNCY forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

UNCY revenue forecast

What is UNCY's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$43.4M
Avg 2 year Forecast
$147.9M
Avg 3 year Forecast
$207.4M

UNCY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
UNCY$1.46$4.50+208.22%Buy
OCUP$2.02$20.00+890.10%Strong Buy
ELDN$2.13$13.00+510.33%Buy
MLEC$1.38$6.00+334.78%Strong Buy
MAIA$2.48N/AN/A

Unicycive Therapeutics Stock Forecast FAQ

Is Unicycive Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: UNCY) stock is to Buy UNCY stock.

Out of 3 analysts, 0 (0%) are recommending UNCY as a Strong Buy, 3 (100%) are recommending UNCY as a Buy, 0 (0%) are recommending UNCY as a Hold, 0 (0%) are recommending UNCY as a Sell, and 0 (0%) are recommending UNCY as a Strong Sell.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.

What is UNCY's revenue growth forecast for 2025-2027?

(NASDAQ: UNCY) Unicycive Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Unicycive Therapeutics's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast UNCY's revenue for 2025 to be $1,507,541,652, with the lowest UNCY revenue forecast at $70,203,890, and the highest UNCY revenue forecast at $2,944,914,169. On average, 2 Wall Street analysts forecast UNCY's revenue for 2026 to be $5,141,635,593, with the lowest UNCY revenue forecast at $685,009,244, and the highest UNCY revenue forecast at $9,598,261,942.

In 2027, UNCY is forecast to generate $7,208,931,627 in revenue, with the lowest revenue forecast at $1,329,355,838 and the highest revenue forecast at $13,088,542,171.

What is UNCY's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: UNCY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is UNCY's Price Target?

According to 3 Wall Street analysts that have issued a 1 year UNCY price target, the average UNCY price target is $4.50, with the highest UNCY stock price forecast at $6.00 and the lowest UNCY stock price forecast at $3.00.

On average, Wall Street analysts predict that Unicycive Therapeutics's share price could reach $4.50 by Mar 14, 2025. The average Unicycive Therapeutics stock price prediction forecasts a potential upside of 208.22% from the current UNCY share price of $1.46.

What is UNCY's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: UNCY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.